We actively communicate on our business, services and technical capabilities. Use the resources on this page to browse through recent news, to subscribe to our news services or to meet us at one of our forthcoming events.
Needle-to-needle’: Manufacturing NeoAntigen peptides
28 Feb 2019 - Trishul Shah of PolyPeptide Laboratories looks at the prospects for individualised peptide therapeutics* […]
Read morePoster: Towards cost-efficient, scalable green SPPS
2019 - Jan Pawlas, Marika Lundqvist, Thomas Svensson, Mikael Nilsson and Jon H. Rasmussen, 25th APS – P280, 2017, Jul 2019 Read more
Read more1,4-Benzenedimethanethiol (1,4-BDMT) as a scavenger for greener peptide resin cleavages
2019 - ) J. Pawlas, T. Svensson and J. H. Rasmussen, RSC Adv., 2019, 9, 38928. Read more
Read morePolyPeptide attends TIDES Europe – Amsterdam, November 7th and 8th
18 Dec 2018 - We will be at stand #13. Simply stop by or schedule an appointment here: [email protected] PolyPeptide attends TIDES Europe in Amsterdam, Postillion Convention Center, November 7th and 8th. […]
Read moreSuitable solvent for cost-efficient green SPPS
10 May 2018 - TamiSolveTM NxG as a suitable solvent for cost-efficient green SPPS[…]
Read moreConsiderations for multi-product manufacturing facilities
30 Jan 2017 - Trishul Shah, Associate Director Business Development at PolyPeptide Laboratories Inc, reviews the considerations for the manufacture of active pharmaceutical ingredients at a multi-product facility.[…]
Read moreDesigning quality into therapeutic peptide manufacturing
1 Dec 2014 - The PolyPeptide Group has embraced quality by design and uses a risk based approach to develop, manufacture and commercialize peptide based therapeutics.[…]
Read moreProcess validation: Manufacturing peptide APIs
28 May 2014 - Trishul Shah of the Polypeptide Group overviews the steps involved in the life-cycle approach encouraged by the US FDA in API manufacture.[…]
Read moreControl strategies for synthetic therapeutic peptide APIs – Part III: Manufacturing process considerations
2014 - I. Eggen, B. Gregg, H. Rode, A. Swietlow, M. Verlander, A. Szajek; BioPharm International, 2014 Read more
Read more